The combined treatment of NAD+ and atorvastatin ameliorates the development of experimental autoimmune encephalomyelitis in C57BL/6 mice
Multiple sclerosis (MS) is a demyelinating and degenerating disorder of the central nervous system impacting many patients worldwide. Due to the complex pathogenesis of MS, drugs to treat MS often show partial effectiveness. Earlier experiments have demonstrated that both atorvastatin and nicotinamide adenine dinucleotide (NAD+) may ameliorate experimental autoimmune encephalomyelitis (EAE), which is known as a classical model of MS, via different protective mechanisms. Since combination therapy can exhibit more beneficial effects than monotherapy, we observed the protective effects of combined treatment of atorvastatin and NAD+ in EAE mice.
Source: Journal of Neuroimmunology - Category: Allergy & Immunology Authors: Huanhuan Sun, Jueqiong Wang, Li Guo, Ying Wang, Jing Zhang, Jinli Wang, Moyuan Quan, Bin Li Source Type: research
More News: Allergy & Immunology | Atorvastatin Calcium | Brain | Lipitor | Multiple Sclerosis | Neurology | Statin Therapy | Zivast